AAAAAA
Results: 26-32/32
Authors:
GANSER A
OTTMANN OG
SEIPELT G
LINDEMANN A
HESS U
GEISSLER G
MAURER A
FRISCH J
SCHULZ G
MERTELSMANN R
HOELZER D
Citation: A. Ganser et al., EFFECT OF LONG-TERM TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-3 INPATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia, 7(5), 1993, pp. 696-701
Authors:
MENTZEL U
GEISSLER G
ROSSOL R
OTTMANN O
MAURER A
GANSER A
HOELZER D
Citation: U. Mentzel et al., DESCRIPTION OF ALPHA-BETA-T-CELLS AND GAMMA-DELTA-T-CELLS IN APLASTIC-ANEMIA, Experimental hematology, 21(8), 1993, pp. 1080-1080
Authors:
GANSER A
MAURER A
BUHL R
OTTMANN OG
SEIPELT G
GEISSLER G
HOELZER D
Citation: A. Ganser et al., RESTORATION OF NORMAL MONOCYTE MACROPHAGE FUNCTION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES DURING HEMATOPOIETIC GROWTH-FACTOR THERAPY (IL-3, GM-CSF)/, Experimental hematology, 21(8), 1993, pp. 1152-1152
Authors:
MAURER A
Citation: A. Maurer, THOMISTS AND AQUINAS,THOMAS ON THE FOUNDATION OF MATHEMATICS, The Review of metaphysics, 47(1), 1993, pp. 43-61
Authors:
VIEGENER J
MAURER A
Citation: J. Viegener et A. Maurer, AN APPROACH TO MAKING THESAURI IN INFORMA TION-SYSTEMS DYNAMIC, Nachrichten fur Dokumentation, 44(5), 1993, pp. 285-292
Authors:
SEIPELT G
GANSER A
DURANCEYK H
MAURER A
OTTMANN OG
HOELZER D
Citation: G. Seipelt et al., INDUCTION OF TNF-ALPHA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES UNDERGOING TREATMENT WITH INTERLEUKIN-3, British Journal of Haematology, 84(4), 1993, pp. 749-751
Authors:
GANSER A
OTTMANN OG
SCHADECKGRESSEL C
KOLBE K
HAAS R
SEIPELT G
MAURER A
ZANDER C
REUTZEL R
HOELZER D
Citation: A. Ganser et al., COMBINATION THERAPY WITH ALL-TRANS-RETINOIC ACID (ATRA), GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF), ERYTHROPOIETIN (EPO) AND VITAMIN-E IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 82(10), 1993, pp. 10000377-10000377